Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365971 · ClinicalTrials.gov registry record
RISE FOR HEALTH Study
A clinical trial of Lower Urinary Tract Symptoms, sponsored by University of Minnesota.
- Completed
- Registry status
- 3,400
- Enrollment target
- 9
- Study locations
NCT05365971 is a study of Lower Urinary Tract Symptoms that has completed, run by University of Minnesota. The registered enrollment target is 3,400 participants, above the 589-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (477% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT05365971, a study of Lower Urinary Tract Symptoms, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 3,400 participants
- Enrollment target
- 9
- Study locations
Study Summary
The RISE FOR HEALTH study (RISE) is an initiative of the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium, which was formed by the NIDDK in 2015 to develop the science to improve bladder health in women and girls. RISE is designed to identify risk and protective factors for bladder health and lower urinary tract symptoms (LUTS) and to estimate the distributions of bladder health and bladder health knowledge, attitudes, and beliefs in women of all ages across the life course. This will be accomplished by conducting a population-based prospective cohort study. A sample of individuals who live within the study base, i.e., the county containing each PLUS clinical research center and each adjacent county, will be invited to complete two baseline surveys and then two follow-up surveys one year later. A subset of participants will be invited to attend an in-person evaluation to collect additional clinical information and biologic specimens.
Conditions Studied
Study Locations (9)
Illinois
- Loyola University Chicago - Chicago
- Northwestern University - Chicago
Alabama
- University of Alabama at Birmingham - Birmingham
California
- University of California, San Diego - San Diego
Connecticut
- Yale University - New Haven
Georgia
- Emory University - Atlanta
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University School of Medicine - St Louis
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,400 participants |
| Start Date | 2022-05-14 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05365971
The ClinicalTrials.gov registry entry for NCT05365971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 589-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (477% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 0 interventions.
NCT05365971 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Illinois, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT05365971 about?
NCT05365971 is a clinical study titled "RISE FOR HEALTH Study". The RISE FOR HEALTH study (RISE) is an initiative of the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium, which was formed by the NIDDK in 2015 to develop the science to improve bladder health in women and girls. RISE is designed to identify risk and protective factors for blad...
What is the current status of trial NCT05365971?
This trial is currently completed. The enrollment target is 3,400 participants. The study started on 2022-05-14. Estimated completion is 2025-06-30.
What conditions does trial NCT05365971 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms.
Who is sponsoring clinical trial NCT05365971?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05365971 being conducted?
This trial has 9 study locations across Alabama, California, Connecticut, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
US Imaging for the Assessment of LUTS
RECRUITING
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
BPH Global Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.